Healthcare provider profile · identity verified

Brandon Michael Mitchell, P.A.-C

Physician Assistant · ANKENY, IA · NPI 1881683498

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	320	88
Levothyroxine Sodium	Levothyroxine Sodium	216	53
Omeprazole	Omeprazole	213	55
Lisinopril	Lisinopril	207	55
Amlodipine Besylate	Amlodipine Besylate	181	53
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	152	23
Losartan Potassium	Losartan Potassium	148	46
Gabapentin	Gabapentin	128	26
Simvastatin	Simvastatin	123	32
Tamsulosin Hcl	Tamsulosin Hcl	114	32
Sertraline Hcl	Sertraline Hcl	101	24
Pantoprazole Sodium	Pantoprazole Sodium	100	28
Hydrochlorothiazide	Hydrochlorothiazide	95	27
Alprazolam	Alprazolam	88	20
Tramadol Hcl	Tramadol Hcl	88	19
Metoprolol Succinate	Metoprolol Succinate	85	21
Ozempic	Semaglutide	83	15
Albuterol Sulfate Hfa	Albuterol Sulfate	71	27
Metformin Hcl Er	Metformin Hcl	70	21
Jardiance	Empagliflozin	69	16
Furosemide	Furosemide	66	19
Tizanidine Hcl	Tizanidine Hcl	65	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	64	11
Metformin Hcl	Metformin Hcl	63	16
Trazodone Hcl	Trazodone Hcl	62	19
Escitalopram Oxalate	Escitalopram Oxalate	61	14
Metoprolol Tartrate	Metoprolol Tartrate	61	16
Celecoxib	Celecoxib	59	suppressed
Meloxicam	Meloxicam	59	18
Warfarin Sodium	Warfarin Sodium	59	12
Rosuvastatin Calcium	Rosuvastatin Calcium	57	19
Duloxetine Hcl	Duloxetine Hcl	56	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	56	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	55	11
Fluoxetine Hcl	Fluoxetine Hcl	54	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	53	17
Prednisone	Prednisone	53	39
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	52	14
Eliquis	Apixaban	46	suppressed
Allopurinol	Allopurinol	45	14
Baclofen	Baclofen	45	suppressed
Bupropion Xl	Bupropion Hcl	44	11
Famotidine	Famotidine	42	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	42	suppressed
Montelukast Sodium	Montelukast Sodium	41	11
Alendronate Sodium	Alendronate Sodium	36	suppressed
Fenofibrate	Fenofibrate	36	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	suppressed
Naproxen	Naproxen	34	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	19
Azithromycin	Azithromycin	32	29
Spiriva Handihaler	Tiotropium Bromide	32	suppressed
Spironolactone	Spironolactone	32	suppressed
Carvedilol	Carvedilol	30	suppressed
Enalapril Maleate	Enalapril Maleate	28	suppressed
Mirtazapine	Mirtazapine	28	suppressed
Pregabalin	Pregabalin	28	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Atenolol	Atenolol	27	suppressed
Clonidine Hcl	Clonidine Hcl	27	suppressed
Buspirone Hcl	Buspirone Hcl	25	suppressed
Clonazepam	Clonazepam	25	suppressed
Divalproex Sodium	Divalproex Sodium	25	suppressed
Glipizide Er	Glipizide	25	suppressed
Ondansetron Odt	Ondansetron	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Lorazepam	Lorazepam	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	21	suppressed
Pravastatin Sodium	Pravastatin Sodium	21	suppressed
Risperidone	Risperidone	21	suppressed
Rybelsus	Semaglutide	21	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Cephalexin	Cephalexin	20	14
Fluticasone Propionate	Fluticasone Propionate	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Amoxicillin	Amoxicillin	18	15
Colchicine	Colchicine	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Potassium Chloride	Potassium Chloride	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	17	suppressed
Eszopiclone	Eszopiclone	17	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Finasteride	Finasteride	17	suppressed
Fluconazole	Fluconazole	17	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	suppressed
Tobramycin	Tobramycin	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Linzess	Linaclotide	16	suppressed
Phenobarbital	Phenobarbital	16	suppressed
Primidone	Primidone	16	suppressed
Glimepiride	Glimepiride	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Nystatin	Nystatin	15	suppressed
Trulicity	Dulaglutide	14	suppressed
Clopidogrel	Clopidogrel Bisulfate	13	suppressed
Glipizide	Glipizide	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Atropine Sulfate	Atropine Sulfate	11	suppressed
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Haloperidol	Haloperidol	11	suppressed
Icosapent Ethyl	Icosapent Ethyl	11	suppressed
Invokana	Canagliflozin	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Tradjenta	Linagliptin	11	suppressed
Xtampza Er	Oxycodone Myristate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error